Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

August 1, 2026

Conditions
Phenylketonuria
Interventions
DRUG

L-carnitine

44 patients diagnosed as a case of phenylketonuria will receive l-carnitine at a dose of 100 mg/kg/day for 1 year and then blood sample will examined for level of brain-derived neurotrophic factor levels before and after therapy and another group composed of 44 patients diagnosed as a case of phenylketonuria will not receive l-carnitine and their blood sample will examined for level of brain-derived neurotrophic factor levels treated and untreated patients will compared with healthy children and infants has same age and sex .

Trial Locations (1)

Unknown

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT06901323 - Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria | Biotech Hunter | Biotech Hunter